Publication date: Jul 20, 2026
To determine whether a Vitamin D oral rinse alters the performance of saliva-based SARS-CoV-2 rapid antigen testing (RAT) and assess its potential implications for infectious disease screening and public health surveillance. In this prospective, paired-sample, single-blind clinical trial, 25 adults with laboratory-confirmed SARS-CoV-2 infection provided saliva immediately before and after a standardized one-minute Vitamin D₃ oral rinse (50 paired specimens). Samples were analyzed in parallel by saliva RAT and rapid RT-PCR under blinded conditions. The oral rinse converted 68% (17/25) of paired specimens from RAT-positive to RAT-negative, reducing antigen positivity from 54. 2% to 32. 0% (p = 0. 0016). In contrast, RT-PCR positivity remained largely preserved (96. 0% vs. 88. 0%), with no significant change in mean Ct values (28. 1 +/- 5. 9 vs. 29. 4 +/- 5. 1; p = 0. 1785). Strong concordance between paired RT-PCR samples (ρ = 0. 814, p
Open Access PDF
| Concepts | Keywords |
|---|---|
| pre-analytical interference | |
| public health surveillance | |
| saliva | |
| SARS-CoV-2 |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Vitamin D |
| disease | MESH | infectious disease |
| pathway | REACTOME | Infectious disease |
| disease | MESH | SARS-CoV-2 infection |
| pathway | REACTOME | SARS-CoV-2 Infection |
| pathway | REACTOME | Reproduction |
| disease | MESH | emergency |
| disease | MESH | infection |
| drug | DRUGBANK | Cholecalciferol |
| pathway | REACTOME | Antimicrobial peptides |
| disease | MESH | bed |